Pharmaceutical Business Review
Regulatory Affairs
Anonymous User | Login

FDA Grants Tentative Approval To GGI For Pramipexole Dihydrochloride Tablets

Published: 28-Dec-2009

Company also received tentaive approval for Atomoxetine Hydrochloride capsules

The FDA has granted tentative approval to Glenmark Generics US (GGI), a subsidiary of Glenmark Generics, for Pramipexole Dihydrochloride tablets, the generic version of Boehringer Ingelheim’s Mirapex tablets.

The tentative approval for Pramipexole Dihydrochloride tablets is for the 0.125mg, 0.25mg, 0.5mg, 1mg, and 1.5mg strengths.

GGI also received tentative approval for Atomoxetine Hydrochloride capsules, the generic version of Lilly’s Strattera.

Atomoxetine Hydrochloride capsules is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). Glenmark’s tentative approval was granted for the 10mg, 18mg, 25mg, 40mg, 60mg, 80mg and 100mg strengths.

The company said that based on the tentative approval for Pramipexole Dihydrochloride tablets, it should be able to launch the product in October 2010, or earlier in certain circumstances.

Reportedly, the company has received ten final and five tentative approvals this calendar year and has well over 40 Abbreviated New Drug Applications (ANDA) pending approval with the FDA.

Glenmark’s current marketing portfolio consists of 49 products authoriSed for distribution in the US.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

World Courier

Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...

Vetter Pharma International

High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...

TOPRA

Healthcare Regulatory Affairs ...

Thomson Reuters

The World's Leading Source of Life Sciences Intelligent Information ...

Tarius

Your One Source for Global Regulatory Information ...

Swiss BioAnalytics

Quantitative and Qualitative LC/MS Services for Preclinical and Clinical Trials ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model

Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Enabling Drug Delivery Deal Making

Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...

Automating Training Control Processes to Comply with FDA Requirements

Well-managed training programs minimize the risk of non-compliance and improve product qua ...

TNO Pharma Services: From Discovery to the Clinic

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

No items to display

Suppliers Product News

World Courier CTSCS Depots Provide Dedicated Storage for GMO Products

In response to growing client demand and based on recently-established international biosafety regulations, World Courier has begun rolling out dedicated storage areas for GMO-derived pharmaceutical products throughout its global investigational drug storage network.

World Courier Triples Clinical Trial Storage Capacity Worldwide with Two New Facilities and Client-Driven Expansion

World Courier expands its GMP-compliant Clinical Trial Supply Chain Services (CTSCS) network, facilitating access to growing pharmaceutical markets in Africa and Australia.

World Courier Achieves Coveted GxP-Compliant Status Worldwide with Focus on GDP, Quality Management

With a fully GxP-compliant transport and supply chain system in place, World Courier meets the most demanding industry requirements for managing time- and temperature-sensitive clinical trial materials used in global studies.

Vetter Dedicates New Facility in Suburban Chicago

The new facility will enable collaboration very early in development process

Pharma Supplier Vetter Shares Pride in Consistent Growth and International Success with Distinguished Visitor Minister zu Guttenberg

Economics and Technology Minister visits global leader's headquarters in southern Germany.

Vetter Packages Success with New Facility

Vetter's new secondary packaging operation allows the company to double its production in half the time.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address